NC hospital reviewing 9,200 cases after lab mistakes wrongly diagnosed cancer

John Gregory | | Health Exec | Quality

After at least 10 patients received improper diagnoses owed to pathology lab errors, Winston Salem, N.C.-based Wake Forest Baptist Medical Center has been reviewing 9,291 cases ahead of a June deadline set by CMS that could strip its Medicare certification.

As North Carolina Health News reports, Wake Forest Baptist’s errors were costly. Of the 10 already identified, three of them underwent unnecessary surgery and radiation treatment in 2016 and 2017, including one who received a double mastectomy despite not having breast cancer. A fourth patient was “underdiagnosed,” only having breast cancer diagnosed 13 months after her biopsy.  

Wake Forest Baptist Still Reviewing Thousands of Pathology Cases

All of those mistakes were attributed to a pathologist identified as “MD #7” in the CMS report, who no longer works at the hospital. But the problems went beyond a single doctor, the agency said, to failure to train workers in the lab or document whether recommended maintenance schedules were followed for lab equipment. Inspectors found failures to “monitor water quality, temperature and humidity levels in the lab,” as well as numerous expired supplies being found on lab shelves dating back as far as 2005.

Wake Forest Baptist didn’t respond to questions about how many case reviews its completed and if any additional patients affected by lab mistakes have been identified.

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Related Content

FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight
The top 25 children's heart hospitals in the US
Study ranks US health system dead last among wealthy nations
The 25 top US hospitals for diabetes care
The 25 best heart hospitals in the United States

Around the web

Cardiovascular Business
FDA sued over ‘reckless and arbitrary’ semaglutide decision

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.